Avidity Partners Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-514,200
Closed -$10.9M 83
2024
Q4
$10.9M Sell
514,200
-312,800
-38% -$8.21M 1.07% 38
2024
Q3
$26.7M Sell
827,000
-479,477
-37% -$14.2M 1.36% 29
2024
Q2
$31.1M Sell
1,306,477
-138,523
-10% -$3.55M 1.32% 28
2024
Q1
$43.1M Buy
1,445,000
+279,068
+24% +$8.73M 1.39% 25
2023
Q4
$37.3M Sell
1,165,932
-172,068
-13% -$4.99M 1.36% 35
2023
Q3
$39.1M Sell
1,338,000
-217,000
-14% -$7.8M 1.58% 27
2023
Q2
$70M Sell
1,555,000
-1,800,900
-54% -$68.7M 2.44% 8
2023
Q1
$116M Buy
3,355,900
+243,900
+8% +$7.92M 3.84% 2
2022
Q4
$86.7M Buy
3,112,000
+2,844,400
+1,063% +$75.3M 1.88% 17
2022
Q3
$6.26M Buy
+267,600
New +$8.55M 0.13% 73
2021
Q1
Sell
-531,000
Closed -$15.4M 121
2020
Q4
$15.4M Buy
+531,000
New +$13.2M 0.5% 57

Other funds holding SGRY

Avidity Partners Management's SGRY Position: Q1 2025 in Review

Avidity Partners Management sold out of Surgery Partners (SGRY) in Q1 2025, closing a stake of 514,200 shares — an estimated $10.9M sold.

Avidity Partners Management first reported a position in SGRY in Q4 2020 and held it in 11 quarters. The position peaked at $116M in Q1 2023. 208 funds tracked by Wall St. Rank hold SGRY as of Q1 2025.

  • Avidity Partners Management reported no remaining Surgery Partners position as of Q1 2025 after selling out during the quarter.
  • Avidity Partners Management sold 514,200 Surgery Partners shares in Q1 2025, an estimated $10.9M.
  • Avidity Partners Management first reported a position in Surgery Partners in Q4 2020 and held it in 11 quarters.
  • Avidity Partners Management's Surgery Partners position peaked at $116M in Q1 2023.
  • 208 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2025.

Based on Avidity Partners Management's 13F filing for Q1 2025, filed 15 May 2025.